JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

El aumento de los niveles plasmáticos de ceramida se asocia con rigidez arterial y envejecimiento vascular: un estudio transversal

  • 0Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China.
Lipids in Health and Disease +

|

1 de septiembre de 2025

|

1 de septiembre de 2025

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

Las ceramidas plasmáticas, particularmente las 22:0 y 24:0, están relacionadas con la rigidez arterial. Estos hallazgos sugieren que las ceramidas pueden servir como biomarcadores para el envejecimiento vascular y la prevención de eventos cardiovasculares.

Área De La Ciencia

  • La bioquímica
  • Medicina cardiovascular
  • Los biomarcadores

Sus Antecedentes

  • Los eventos cardiovasculares (CV) son una preocupación importante para la salud.
  • Las ceramidas plasmáticas muestran un valor predictivo para los eventos cardiovasculares.
  • El vínculo entre las ceramidas plasmáticas y la rigidez arterial requiere más investigación.

Objetivo Del Estudio

  • Explorar las asociaciones entre los niveles plasmáticos de ceramida y la rigidez arterial.
  • Investigar la correlación de las proporciones específicas de ceramida con la rigidez arterial.

Principales Métodos

  • Diseño del estudio retrospectivo.
  • Análisis de regresión multivariada y de spline cúbico restringido (RCS).
  • Análisis de la curva de las características de funcionamiento del receptor (ROC) para el valor diagnóstico.

Principales Resultados

  • Ceramidas plasmáticas 24: 0 y 22: 0 asociadas significativamente con rigidez arterial.
  • Se encontró una correlación no lineal para la ceramida plasmática 22: 0 (P=0, 04).
  • El análisis de ROC indicó un rendimiento diagnóstico aceptable para ambas ceramidas (AUCs 0,702-0,724).

Conclusiones

  • Los niveles plasmáticos de ceramida se correlacionan significativamente con la rigidez arterial.
  • Las ceramidas pueden actuar como biomarcadores para el envejecimiento vascular.
  • Valor potencial para las estrategias de prevención temprana contra eventos cardiovasculares.

Palabras clave:

Videos de Conceptos Relacionados

Coronary Artery Disease I: Introduction 01:30

54

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Atherosclerosis I: Introduction 01:30

76

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Peripheral Artery Disease I: Introduction 01:30

32

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Coronary Artery Disease II: Pathophysiology 01:26

33

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests 01:27

38

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis III: Management 01:26

33

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...